PWA
SUPN icon

Physician Wealth Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Physician Wealth Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-31
Closed -$1.02K – 1962
2025
Q1 		$1.02K Buy
+31
New +$1.1K ﹤0.01% 1045

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Physician Wealth Advisors's SUPN Position: Q2 2025 in Review

Physician Wealth Advisors sold out of Supernus Pharmaceuticals (SUPN) in Q2 2025, closing a stake of 31 shares — an estimated $1.02K sold.

Physician Wealth Advisors first reported a position in SUPN in Q1 2025 and held it in 1 quarter. The position peaked at $1.02K in Q1 2025. 295 funds tracked by Wall St. Rank hold SUPN as of Q2 2025.

  • Physician Wealth Advisors reported no remaining Supernus Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Physician Wealth Advisors sold 31 Supernus Pharmaceuticals shares in Q2 2025, an estimated $1.02K.
  • Physician Wealth Advisors first reported a position in Supernus Pharmaceuticals in Q1 2025 and held it in 1 quarter.
  • Physician Wealth Advisors's Supernus Pharmaceuticals position peaked at $1.02K in Q1 2025.
  • 295 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2025.

Based on Physician Wealth Advisors's 13F filing for Q2 2025, filed 14 Jul 2025.